Haloperidol
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72888-173 -
Package NDC
72888-173-47 -
Package NDC
72888-173-48 -
Application number
ANDA218371 -
SPL ID
45c7bbb4-7235-89a8-e063-6394a90a7ea0 -
SPL set ID
8bfdc739-51b4-4914-9a60-923e83762307 -
UNII
J6292F8L3D -
RxCUI
141935
What the source publishes
- Labeler
- Advagen Pharma Ltd
- Active ingredients
- Haloperidol
- Form
- SOLUTION, CONCENTRATE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Haloperidol",
"splId": "45c7bbb4-7235-89a8-e063-6394a90a7ea0",
"labels": [
{
"setId": "8bfdc739-51b4-4914-9a60-923e83762307",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bfdc739-51b4-4914-9a60-923e83762307",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8bfdc739-51b4-4914-9a60-923e83762307"
}
],
"routes": [
"ORAL"
],
"labeler": "Advagen Pharma Ltd",
"finished": true,
"packaging": [
{
"sample": false,
"description": "15 mL in 1 BOTTLE (72888-173-47)",
"package_ndc": "72888-173-47",
"identifierStatus": "well-formed",
"marketing_start_date": "20240131"
},
{
"sample": false,
"description": "120 mL in 1 BOTTLE (72888-173-48)",
"package_ndc": "72888-173-48",
"identifierStatus": "well-formed",
"marketing_start_date": "20240131"
}
],
"productId": "72888-173_45c7bbb4-7235-89a8-e063-6394a90a7ea0",
"useDomain": "unknown",
"dosageForm": "SOLUTION, CONCENTRATE",
"productNdc": "72888-173",
"deaSchedule": null,
"genericName": "Haloperidol",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HALOPERIDOL",
"strength": "2 mg/mL"
}
],
"applicationNumber": "ANDA218371",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240131",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000180182"
],
"upc": [
"0372888173474",
"0372888173481"
],
"unii": [
"J6292F8L3D"
],
"rxcui": [
"141935"
],
"spl_set_id": [
"8bfdc739-51b4-4914-9a60-923e83762307"
],
"pharm_class_epc": [
"Typical Antipsychotic [EPC]"
],
"manufacturer_name": [
"Advagen Pharma Ltd"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72888-173_45c7bbb4-7235-89a8-e063-6394a90a7ea0"